Armata Pharmaceuticals (ARMP) Preferred Stock Liabilities (2013 - 2016)

Armata Pharmaceuticals has disclosed Preferred Stock Liabilities across 4 years of filings, most recently posting $13.6 million for Q1 2016.

• Preferred Stock Liabilities for Q1 2016 came in at $13.6 million, up 484.84% year-over-year; the trailing twelve-month figure through Mar 2016 was $13.6 million (up 484.84% YoY), and the FY2015 annual result was $11.9 million, up 497.49% from the prior year.
• Preferred Stock Liabilities came in at $13.6 million for Q1 2016 at Armata Pharmaceuticals, up from $11.9 million in the prior quarter.
• In the past five years, Preferred Stock Liabilities ranged from a high of $46.3 million in Q1 2014 to a low of $707000.0 in Q4 2013.
• The 4-year median for Preferred Stock Liabilities is $3.2 million (2015), against an average of $9.5 million.
• Peak annual rise in Preferred Stock Liabilities reached 559.1% in 2015, while the deepest fall reached 94.97% in 2015.
• Armata Pharmaceuticals' Preferred Stock Liabilities stood at $707000.0 in 2013, then soared by 181.47% to $2.0 million in 2014, then surged by 497.49% to $11.9 million in 2015, then grew by 14.51% to $13.6 million in 2016.
• The last three Preferred Stock Liabilities figures came in at $13.6 million (Q1 2016), $11.9 million (Q4 2015), and $10.9 million (Q3 2015), per Business Quant data.